Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

NCT00198588 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8

Enrollment

OTHER_GOV

Sponsor class

Conditions

Heparin-Induced Thrombocytopenia

Interventions

DRUG: argatroban

Sponsor

Ministry of Health, Labour and Welfare, Japan

Collaborators

[object Object]